Skip to main content
Realcan Pharmaceutical Group Co.,Ltd. logo

Realcan Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 002589 ISIN · CNE1000013X5 LEI · 300300YI5IV3FBRRSJ48 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,678 across all filing types
Latest filing 2026-04-22 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002589

About Realcan Pharmaceutical Group Co.,Ltd.

https://www.realcan.cn

Realcan Pharmaceutical Group Co., Ltd. specializes in the distribution of pharmaceutical products, medical devices, and healthcare consumables. The company operates an extensive supply chain network, providing integrated logistics and distribution services primarily to medical institutions and healthcare providers. Its core operations include the procurement, storage, and delivery of a wide range of medical supplies, supported by advanced information management systems and cold-chain logistics capabilities. Realcan also offers value-added services such as hospital supply chain optimization, third-party logistics, and financial solutions tailored to the healthcare industry. By focusing on a direct-to-hospital distribution model, the company aims to enhance the efficiency of medical supply procurement and ensure the timely delivery of critical healthcare products.

Recent filings

Filing Released Lang Actions
上市公司2025年度非经常性资金占用及其他关联资金往来情况汇总表
Regulatory Filings Classification · 85% confidence The document consists of detailed summary tables of ‘non-operating fund occupation and other related party fund flows’ for various listed companies in 2025. It is clearly the substantive data itself (multiple pages of tables) rather than an announcement that a report is available. This content does not correspond to any specific category like an Annual Report, Interim Report, Earnings Release, Audit Report, or Investor Presentation. There is no narrative MD&A, no dividend notice, no management or board change, no financing update, nor any transcript. It is a regulatory disclosure of related‐party transactions required by the exchange and thus falls under the generic “Regulatory Filings” catch‐all. Therefore, the correct classification is RNS.
2026-04-22 Chinese
关于全资子公司为上市公司提供担保的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a guarantee provided by the company's wholly-owned subsidiaries for the listed company. It details the guarantee amount, involved parties, internal approvals, financial data summary, and compliance with regulatory requirements. There is no indication that this is a full financial report, audit report, or earnings release. It is a regulatory announcement about financing guarantees and related approvals, which fits best under the category of Regulatory Filings (RNS). The document length is relatively short (2773 characters), and it is not a report publication announcement or certification. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2026-04-10 Chinese
关于实际控制人部分股份解除质押的公告
Transaction in Own Shares Classification · 95% confidence The document is a public announcement from 瑞康医药集团股份有限公司 regarding the release of pledged shares by the actual controller and details about the pledged shares held by major shareholders. It includes specific data on share pledges, dates, and shareholder information. The document is short (1355 characters) and focuses on share pledge status and related risks, not on financial results, management changes, or legal proceedings. This type of announcement fits the category of Transaction in Own Shares (POS), as it reports on changes in share pledging status by insiders or controlling shareholders.
2026-04-03 Chinese
关于董事、董事会秘书及副总裁解除责令候查的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the lifting of investigation measures on a company's director, board secretary, and vice president. It references previous announcements about the imposition and lifting of such measures. The content focuses on management personnel status updates rather than financial results, reports, or regulatory filings. There is no indication of financial data, audit information, or shareholder voting results. This fits the category of Board/Management Information (MANG), which covers announcements about changes or status updates in the company's board or senior management.
2026-02-13 Chinese
2026年第一次临时股东会决议的公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an announcement of the resolutions passed at the 2026 first extraordinary general meeting (临时股东会) of 瑞康医药集团股份有限公司. It includes details about the meeting notice, attendance, voting results, and legal opinion on the meeting's validity. The document does not contain financial statements or detailed financial analysis but reports the official voting results of shareholder decisions, specifically the approval of changing the accounting firm. The document length is short (1549 characters) and is clearly an announcement of voting results from a shareholder meeting. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-01-12 Chinese
2026年第一次临时股东会的律师见证法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, procedures, attendance, and voting results of the 2026 first extraordinary shareholders' meeting of Ruikang Pharmaceutical Group Co., Ltd. It details the legal compliance of the meeting's call, attendance, agenda, and voting process. The document does not contain financial statements or financial performance data, nor is it a report of voting results alone. It is a legal opinion on the shareholders' meeting process and resolutions. This type of document is best classified as a Regulatory Filing (RNS) because it is a legal compliance and procedural attestation related to a shareholders' meeting, not the meeting materials themselves (AGM-R), nor the voting results announcement (DVA). The document length is under 5,000 characters, but it is a substantive legal opinion, not a mere announcement of a report publication (RPA). Therefore, the most appropriate classification is Regulatory Filings (RNS).
2026-01-12 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.